利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

19 条记录 (耗时 0.023 秒)

    Antibody to antigen specifically expressed on the surface of B cells and Hodgkin's cells
    3.
    发明授权
    Antibody to antigen specifically expressed on the surface of B cells and Hodgkin's cells 失效
    在B细胞和霍奇金细胞表面上特异性表达的抗原抗体

    公开(公告)号：US5658743A

    公开(公告)日：1997-08-19

    申请号：US229364

    申请日：1994-04-18

    申请人： Ashraf Imam ,  Clive R. Taylor

    发明人： Ashraf Imam ,  Clive R. Taylor

    IPC分类号： C07K14/705 ,  C07K16/28 ,  C07K16/30 ,  G01N33/53 ,  G01N33/574

    CPC分类号： C07K14/705 ,  C07K16/28 ,  C07K16/3061 ,  C07K2317/73 ,  Y10S530/837

    摘要： The invention relates to a new antigen termed BLA-36 specifically expressed on the surface of Hodgkin's cells, Reed-Sternberg cells and B lymphocytes, and to a new monoclonal antibody (anti-BLA-36) specific thereto. The antigen is characterized by the following properties:a molecular weight of about 36,000 D;the presence of an epitope recognized by antibody to said protein;specific expression by Hodgkin's cells and Reed-Sternberg cells in all subsets of Hodgkin's disease, and by activated and early proliferating B cells;no expression by T cells;capability of reacting with its antibody in both frozen and fixed/paraffin embedded tissues;a function associated with the growth of cells capable to express said antigen protein.

    摘要翻译： 本发明涉及在霍奇金细胞，Reed-Sternberg细胞和B淋巴细胞表面特异性表达的称为BLA-36的新抗原，以及与其特异性的新的单克隆抗体（抗BLA-36）。 抗原的特征在于以下性质：分子量约36,000D; 存在抗体对所述蛋白质识别的表位; Hodgkin's细胞和Reed-Sternberg细胞在霍奇金病的所有亚型中的特异性表达，以及活化和早期增殖的B细胞; T细胞无表达; 在冷冻和固定/石蜡包埋组织中与其抗体反应的能力; 与能够表达所述抗原蛋白的细胞的生长相关的功能。

    Antigen specifically expressed on the surface of B cells and Hodgkin's cells
    4.
    发明授权
    Antigen specifically expressed on the surface of B cells and Hodgkin's cells 失效
    抗原特异性表达于B细胞和霍奇金细胞表面

    公开(公告)号：US5304635A

    公开(公告)日：1994-04-19

    申请号：US994082

    申请日：1992-12-16

    申请人： Ashraf Imam ,  Clive R. Taylor

    发明人： Ashraf Imam ,  Clive R. Taylor

    IPC分类号： C07K14/705 ,  C07K16/28 ,  C07K16/30 ,  C07K15/00 ,  A61K35/14

    CPC分类号： C07K14/705 ,  C07K16/28 ,  C07K16/3061 ,  C07K2317/73 ,  Y10S530/837

    摘要： The invention relates to a new antigen termed BLA-35 specifically expressed on the surface of Hodgkin's cells, Reed-Sternberg cells and B lymphocytes, and to a new monoclonal antibody (anti-BLA-36) specific thereto. The antigen is characterized by the following properties:a molecular weight of about 36,000 D;the presence of an epitope recognized by antibody to said protein;specific expression by Hodgkin's cells and Reed-Sternberg cells in all subsets of Hodgkin's disease, and by activated and early proliferating B cells;no expression by T cells;capability of reacting with its antibody in both frozen and fixed/paraffin embedded tissues;a function associated with the growth of cells capable to express said antigen protein.

    摘要翻译： 本发明涉及在霍奇金细胞，Reed-Sternberg细胞和B淋巴细胞表面特异性表达的称为BLA-35的新抗原，以及与其特异性的新的单克隆抗体（抗BLA-36）。 抗原的特征在于以下性质：分子量约36,000D; 存在抗体对所述蛋白质识别的表位; Hodgkin's细胞和Reed-Sternberg细胞在霍奇金病的所有亚型中的特异性表达，以及活化和早期增殖的B细胞; T细胞无表达; 在冷冻和固定/石蜡包埋组织中与其抗体反应的能力; 与能够表达所述抗原蛋白的细胞的生长相关的功能。

    Detection of necrotic malignant tissue and associated therapy
    5.
    发明授权
    Detection of necrotic malignant tissue and associated therapy 失效
    检测坏死性恶性组织及相关治疗

    公开(公告)号：US5019368A

    公开(公告)日：1991-05-28

    申请号：US314437

    申请日：1989-02-23

    申请人： Alan L. Epstein ,  Clive R. Taylor

    发明人： Alan L. Epstein ,  Clive R. Taylor

    IPC分类号： A61K38/00 ,  A61K47/48 ,  A61K49/04 ,  A61K49/16 ,  A61K51/10 ,  C07K16/30 ,  G01N33/574

    CPC分类号： G01N33/57496 ,  A61K47/48384 ,  A61K47/48569 ,  A61K49/04 ,  A61K49/16 ,  A61K51/1018 ,  A61K51/1045 ,  C07K16/30 ,  C07K16/3061 ,  A61K2121/00 ,  A61K2123/00 ,  A61K38/00 ,  C07K2317/54

    摘要： Disclosed is a method for enhancing the effects of therapy that kills malignant cells in vivo comprising the steps of obtaining monoclonal antibody that is specific to an internal cellular component of a mammal but not to external cellular components, wherein the monoclonal antibody is attached to an antineoplastic agent; initiating therapy in a mammal to kill malignant cells in vivo, thereby causing some of the malignant cells to become necrotic; and administering the antibodies to the mammal. The antibodies bind to the necrotic malignant cells thereby delivering antineoplastic agent to surrounding cells. Also disclosed is a method of de novo therapy comprising administration of antibody-antineoplastic agent conjugate such that antineoplastic agent is delivered to the tumor. Also disclosed are antibodies for use with the foregoing methods and for use with diagnositc methods.

    摘要翻译： 公开了一种用于增强在体内杀死恶性细胞的治疗效果的方法，包括获得对哺乳动物的内部细胞成分特异但不与外部细胞成分特异的单克隆抗体的步骤，其中单克隆抗体连接于抗肿瘤 代理人 在哺乳动物中开始治疗以在体内杀死恶性细胞，从而导致一些恶性细胞变坏; 并向哺乳动物施用抗体。 抗体结合坏死性恶性细胞，从而将抗肿瘤剂递送至周围细胞。 还公开了一种从头治疗的方法，其包括施用抗 - 抗肿瘤剂缀合物，使得抗肿瘤剂递送至肿瘤。 还公开了与上述方法一起使用并用于诊断方法的抗体。

    Compositions and Methods for Identifying Single Antigens or Other Molecules in Cell Preparations
    6.
    发明申请
    Compositions and Methods for Identifying Single Antigens or Other Molecules in Cell Preparations 审中-公开
    在细胞制剂中鉴定单一抗原或其他分子的组合物和方法

    公开(公告)号：US20140113385A1

    公开(公告)日：2014-04-24

    申请号：US13877436

    申请日：2011-10-21

    申请人： Clive R. Taylor

    发明人： Clive R. Taylor

    IPC分类号： G01N33/543

    CPC分类号： G01N33/54313

    摘要： Disclosed are compositions and methods for identifying and preferably quantifying single antigens/molecules in tissue sections and other cell preparations. The methods make use of specific antibodies or aptomers linked with beads or other micro-particles using bright field microscopy having the purpose to identify and quantify single antigens or other molecules.

    摘要翻译： 公开了用于鉴定和优选地定量组织切片和其它细胞制剂中的单个抗原/分子的组合物和方法。 该方法利用具有目的来鉴定和定量单个抗原或其他分子的明视野显微镜，利用与珠粒或其他微粒子连接的特异性抗体或起始物。

    Detection of necrotic malignant tissue and associated therapy
    10.
    发明授权
    Detection of necrotic malignant tissue and associated therapy 失效
    检测坏死性恶性组织及相关治疗

    公开(公告)号：US6017514A

    公开(公告)日：2000-01-25

    申请号：US268543

    申请日：1999-03-11

    申请人： Alan L. Epstein ,  Clive R. Taylor

    发明人： Alan L. Epstein ,  Clive R. Taylor

    IPC分类号： A61K38/00 ,  A61K47/48 ,  A61K49/04 ,  A61K49/16 ,  A61K51/10 ,  C07K16/30 ,  G01N33/574 ,  A61K49/00 ,  G01N31/00 ,  G01N33/48

    CPC分类号： G01N33/57496 ,  A61K47/48384 ,  A61K47/48569 ,  A61K49/04 ,  A61K49/16 ,  A61K51/1018 ,  A61K51/1045 ,  C07K16/30 ,  C07K16/3061 ,  A61K2121/00 ,  A61K2123/00 ,  A61K38/00 ,  C07K2317/54

    摘要： Disclosed is a method for measuring the effectiveness of therapy intended to kill malignant cells in vivo in a mammal, comprising the steps of obtaining monoclonal antibody that is specific to an internal cellular component of the mammal but not to external cellular components, wherein the monoclonal antibody is labeled; contacting the labeled antibody with tissue of a mammal that has received therapy to kill malignant cells in vivo, and determining the effectiveness of the therapy by measuring the binding of the labeled antibody to the internal cellular component. The internal cellular component is preferably insoluble intracellular antigen, and the label is preferably a radionuclide, a radiopaque material, or a magnetic resonance-enhancing material. Also disclosed is a method whereby the antibody to insoluble intracellular antigen is conjugated to an antineoplastic agent, so that upon administration of the antibody-antineoplastic agent conjugate, antineoplastic agent may be delivered to the tumor. Also disclosed are antibodies for use with the foregoing methods.

    摘要翻译： 公开了一种测量用于在哺乳动物体内杀死恶性细胞的治疗效果的方法，包括以下步骤：获得对哺乳动物的内部细胞成分特异但不与外部细胞成分特异的单克隆抗体，其中单克隆抗体 被标记 使标记的抗体与已经接受治疗以在体内杀死恶性细胞的哺乳动物的组织接触，并通过测量标记的抗体与内部细胞组分的结合来确定治疗的有效性。 内部细胞组分优选为不溶性细胞内抗原，并且标记物优选为放射性核素，不透射线材料或磁共振增强材料。 还公开了一种使不溶性细胞内抗原的抗体与抗肿瘤剂缀合的方法，使得在施用抗体 - 抗肿瘤剂缀合物时，可将抗肿瘤药递送至肿瘤。 还公开了与上述方法一起使用的抗体。